<DOC>
	<DOCNO>NCT00171145</DOCNO>
	<brief_summary>This study assess efficacy 12-week treatment darifenacin increase warning time , time first sensation urgency voiding , patient OAB .</brief_summary>
	<brief_title>A 12-Week Study Evaluate Efficacy Darifenacin Increase Warning Time Patients With Overactive Bladder .</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Three symptom OAB ( urge incontinence , frequency urgency ) least six month prior Visit 2 . Patients capable independent toileting able independently complete patient diary . Patients use anticholinergic drug contraindicate Evidence severe liver disease Patients clinically significant urinary gynecological condition Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Overactive Bladder , incontinence , antimuscarinic , warning time , darifenacin</keyword>
</DOC>